Download PDF
doi: 10.53388/ghr2020-12-026
Published online: December 12, 2020
Citation: Long ZZ, Nie QH. Research Progress and Reflection on New Drugs for the Treatment of Chronic Hepatitis B. Gastroenterol & Hepatol Res. 2020;2(4):125-131. doi: 10.53388/ghr2020-12-026.
Chronic hepatitis B (CHB) affects more than 257 million individuals with high liver-related morbidity and mortality worldwide. This review summarizes research progress and reflection on new drugs for the treatment of CHB. Some available HBV therapeutic strategies and their corresponding stages of development from preclinical to various clinical phases are indicated in this article. Through this review, the author aims to give us a comprehensive understanding of the global research trends and the latest progress of new drugs for treating chronic hepatitis B, so as to gain useful enlightenment.
Copyright © 2025 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.